Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria

被引:1133
作者
Borch-Johnsen, K
Neil, A
Balkau, B
Larsen, S
Nissinen, A
Pekkanen, J
Tuomilehto, J
Jousilahti, P
Lindstrom, J
Pyörälä, M
Pyörälä, K
Eschwege, E
Gallus, G
Garancini, MP
Bouter, LM
Dekker, JM
Heine, RJ
Nijpels, HG
Stehouwer, CDA
Feskens, EJM
Kromhout, D
Peltonen, M
Pajak, A
Eriksson, J
Qiao, Q
机构
[1] Diabetes/Genetic Epidemiology Unit, Dept. of Epidemiol./Health Promotion, National Public Health Institute, FIN-O0300 Helsinki
关键词
D O I
10.1001/archinte.161.3.397
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: New diagnostic criteria for diabetes based on fasting blood glucose (FBG) level were approved by the American Diabetes Association. The impact of using FBG only has not been evaluated thoroughly. The fasting and the 2-hour glucose (2h-BG) criteria were compared with regard to the prediction of mortality. Methods: Existing baseline data on glucose level at fasting and 2 hours after a 75-g oral glucose tolerance test from 10 prospective European cohort studies including 15388 men and 7126 women aged 30 to 89 years, with a median follow-up of 8.8 years, were analyzed. Hazards ratios for death from all causes, cardiovascular disease, coronary heart disease, and stroke were estimated. Results: Multivariate Cox regression analyses showed that the inclusion of FBG did not add significant information on the prediction of 2h-BG alone (P>.10 for various causes), whereas the addition of 2h-BG to FBG criteria significantly improved the prediction (P<.001 for all causes and P<.005 for cardiovascular disease). In a model including FBG and 2h-BG simultaneously, hazards ratios (95% confidence intervals) in subjects with diabetes on 2h-BG were 1.73 (1.45-2.06) for all causes, 1.40 (1.02-1.92) for cardiovascular disease, 1.56 (1.03 2.36) for coronary heart disease, and 1.29 (0.66-2.54) for stroke mortality, compared with the normal 2h-BG group. Compared with the normal FBG group, the corresponding hazards ratios in subjects with diabetes on FBG were 1.21(1.01-1.44), 1.20 (0.88-1.64), 1.09 (0.71-1.67), and 1.64 (0.88-3.07), respectively. The largest number of excess deaths was observed in subjects who had impaired glucose tolerance but normal FBG levels. Conclusions: The 2h-BG is a better predictor of deaths from all causes and cardiovascular disease than is FBG.
引用
收藏
页码:397 / 405
页数:9
相关论文
共 40 条
  • [1] ALBERTI KGM, 1999, DEFINITION DIAGNOS 1
  • [2] [Anonymous], 1999, Diabetologia, V42, P647
  • [3] RISK-FACTORS FOR EARLY DEATH IN NON-INSULIN-DEPENDENT DIABETES AND MEN WITH KNOWN GLUCOSE-TOLERANCE STATUS
    BALKAU, B
    ESCHWEGE, E
    PAPOZ, L
    RICHARD, JL
    CLAUDE, JR
    WARNET, JM
    DUCIMETIERE, P
    [J]. BRITISH MEDICAL JOURNAL, 1993, 307 (6899) : 295 - 299
  • [4] THE HIGH-RISK OF DEATH BY ALCOHOL RELATED DISEASES IN SUBJECTS DIAGNOSED AS DIABETIC AND IMPAIRED GLUCOSE TOLERANT - THE PARIS PROSPECTIVE-STUDY AFTER 15 YEARS OF FOLLOW-UP
    BALKAU, B
    ESCHWEGE, E
    DUCIMETIERE, P
    RICHARD, JL
    WARNET, JM
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (06) : 465 - 474
  • [5] Non-cardiovascular disease mortality and diabetes mellitus
    Balkau, B
    Pyorala, A
    Shipley, M
    Forhan, A
    Jarrett, J
    Eschwege, E
    Pyorala, K
    [J]. LANCET, 1997, 350 (9092) : 1680 - 1680
  • [6] High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men -: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study
    Balkau, B
    Shipley, M
    Jarrett, RJ
    Pyörälä, K
    Pyörälä, M
    Forhan, A
    Eschwège, E
    [J]. DIABETES CARE, 1998, 21 (03) : 360 - 367
  • [7] IS BORDERLINE FASTING HYPERGLYCEMIA A RISK FACTOR FOR CARDIOVASCULAR DEATH
    BARRETTCONNOR, E
    WINGARD, DL
    CRIQUI, MH
    SUAREZ, L
    [J]. JOURNAL OF CHRONIC DISEASES, 1984, 37 (9-10): : 773 - 779
  • [8] Fasting blood glucose: An underestimated risk factor for cardiovascular death - Results from a 22-year follow-up of healthy nondiabetic men
    Bjornholt, JV
    Erikssen, G
    Aaser, E
    Sandvik, L
    Nitter-Hauge, S
    Jervell, J
    Erikssen, J
    Thaulow, E
    [J]. DIABETES CARE, 1999, 22 (01) : 45 - 49
  • [9] Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371
  • [10] Borch-Johnsen K, 1999, LANCET, V354, P617